Atossa Therapeutics Inc. (ATOS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear

Atossa Therapeutics Inc.

NASDAQ: ATOS · Real-Time Price · USD
1.01
0.09 (9.78%)
At close: Oct 03, 2025, 3:59 PM
1.01
-0.03%
After-hours: Oct 03, 2025, 07:50 PM EDT

Atossa Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
71.08M 88.46M 110.89M 136.38M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a 1.71M 4.7M n/a
Other Long-Term Assets
1.99M 2.32M 634K 1K
Receivables
n/a -1.43M 743K 1.07M
Inventory
n/a 1.49M 5.25M 2.6M
Other Current Assets
229K 110K 110K -1.29M
Total Current Assets
74.46M 92.22M 118.2M 141.24M
Property-Plant & Equipment
n/a n/a n/a 20K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
1.99M 4.03M 5.33M 22K
Total Assets
76.44M 96.25M 123.53M 141.26M
Account Payables
679K 806K 2.96M 1.72M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a n/a n/a
Other Current Liabilities
3.04M 1.8M 1.08M 225K
Total Current Liabilities
4.97M 5.24M 5.57M 3.13M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a 2.96M 1.72M
Total Liabilities
4.97M 5.24M 5.57M 3.13M
Total Debt
n/a n/a n/a n/a
Book Value
71.48M 91.02M 117.96M 138.14M
Book Value Per Share
0.57 0.72 0.93 1.18
Common Stock
23.49M 22.79M 22.79M 22.79M
Retained Earnings
-211.79M -186.29M -156.19M -129.23M
Comprehensive Income
n/a n/a n/a -582K
Shareholders Equity
71.48M 91.02M 117.96M 138.14M
Total Investments
n/a 1.71M 4.7M n/a